National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 1700-1701 [E9-400]
Download as PDF
<![CDATA[
1700
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
Name of Committee: National Institute on
Drug Abuse, Special Emphasis Panel, NIDA–
E Conflicts.
Date: February 11, 2009.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave., NW., Washington, DC 20037.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, 301–451–4530,
elazarwe@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse; Initial Review Group;
Medication Development Research
Subcommittee.
Date: February 12, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications
Place: Double Tree Hotel, 1515 Rhode
Island Avenue, NW., Washington, DC 20005.
Contact Person: Jose F Ruiz, PhD,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Blvd., Rm. 213, MSC 8401, Bethesda, MD
20892, 301–451–3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse; Initial Review Group Training
and; Career Development Subcommittee.
Date: March 17–18, 2009.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892–8401, 301–451–4530,
el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–280 Filed 1–12–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
National Diabetes and Digestive and
Kidney Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: February 18, 2009.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: To present the Director’s Report
and other scientific Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 4:10 p.m. to 4:40 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases, Advisory
Council, Diabetes, Endocrinology, and
Metabolic Diseases Subcommittee.
Date: February 18, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases, Advisory
Council, Digestive Diseases and Nutrition
Subcommittee.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Date: February 18, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division Of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases, Advisory
Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: February 18, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institutes/Center’s home page: https://
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\13JAN1.SGM
13JAN1
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
Dated: January 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–400 Filed 1–12–09; 8:45 am]
Dated: January 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–401 Filed 1–12–09; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group Biological Aging
Review Committee.
Date: February 6, 2009.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Rm. 2C212, Bethesda, MD 20814. (Telephone
Conference Call)
Contact Person: Bita Nakhai, PhD,
Scientific Review Administrator, Scientific
Review Office, National Institute on Aging,
Gateway Bldg., 2C–212, 7201 Wisconsin
Avenue, Bethesda, MD 20814, 301–402–
7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group, Neuroscience of
Aging Review Committee.
Date: March 5–6, 2009.
Time: 4 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Chevy Chase, 4300
Military Road, NW., Washington, DC 20015.
Contact Person: William Cruce, PhD,
Scientific Review Administrator, National
Institute on Aging, Scientific Review Office,
Gateway Building 2C–212, 7201 Wisconsin
Ave., Bethesda, MD 20814, 301–402–7704,
crucew@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review of R03 and R21
applications.
Date: February 11, 2009.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Jonathan Horsford, PhD,
Scientific Review Officer, Natl. Inst. of Dental
and Craniofacial Research, National Institutes
of Health, 6701 Democracy Blvd, Room 664,
Bethesda, MD 20892, 301–594–4859.
horsforj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–420 Filed 1–12–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trials.
Date: February 10, 2009.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/National Institutes of Health/NIAID,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892–7616, 301–402–7098,
pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–424 Filed 1–12–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2009–0001]
Homeland Security Information
Network Advisory Committee
ACTION: Committee Management; Notice
of Rescheduling of Federal Advisory
Committee Teleconference Meeting.
SUMMARY: The Homeland Security
Information Network Advisory
Frm 00040
Fmt 4703
Sfmt 4703
1701
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Pages 1700-1701]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-400]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Diabetes and Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: February 18, 2009.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: To present the Director's Report and other scientific
Presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: 4:10 p.m. to 4:40 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases, Advisory Council, Diabetes, Endocrinology, and Metabolic
Diseases Subcommittee.
Date: February 18, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases, Advisory Council, Digestive Diseases and Nutrition
Subcommittee.
Date: February 18, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division Of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases, Advisory Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: February 18, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institutes/Center's home
page: https://www.niddk.nih.gov/fund/divisions/DEA/Council/
coundesc.htm., where an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 1701]]
Dated: January 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-400 Filed 1-12-09; 8:45 am]
BILLING CODE 4140-01-M
